Plant Tissue Culture Market Size Global Report, 2022 - 2030
Plant Tissue Culture Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030

Plant Tissue Culture Market Share, Size, Trends, Industry Analysis Report, By End-Use (Agriculture, Research, Gardening & Decoration, Forestry & Botanical Garden, Others); By Crop Type; By Stage; By Region; Segment Forecast, 2022 - 2030

  • Published Date:May-2022
  • Pages: 117
  • Format: PDF
  • Report ID: PM2383
  • Base Year: 2021
  • Historical Data: 2018 - 2020

Report Outlook

The global plant tissue culture market was valued at USD 390.0 million in 2021 and is expected to grow at a CAGR of 8.6% during the forecast period. The plant tissue culture market is expected to be driven by numerous genetic engineering techniques. This cell culture method can be a renewable supply of valuable pharmaceutical compounds, colorants, aromas, and flavors that would be difficult to manufacture using chemical synthesis or microbial cells.

Plant Tissue Culture Market SizeKnow more about this reportrequest for sample pages

Furthermore, this approach could provide a consistent and stable source of herbal medications. The number of natural compounds obtained utilizing cell cultures is enormous and steadily increasing. Unlike microorganism cultivation, the cells are cultivated on a huge scale in a fermenter.

These benefits include a continual supply of plants as raw materials as well as the creation of wholly novel chemicals under controlled conditions. Furthermore, cell culture is recognized as the most advanced technology for crop improvement through the generation of somaclonal and gameto clonal variations.

The micropropagation method has enormous potential for producing high-quality plants and isolating beneficial variants in very well high-yielding cultivars with improved resistance to disease and drought resistance. As a result, it will enhance plant tissue culture market growth. However, tissue cultivation is labor-intensive, time-consuming, and can be pricey, which will restrict the industry's growth.

Industry Dynamics

Growth Drivers
Transgenic crops are in high demand due to the numerous advantages they provide, such as increased yield, efficiency, and quality and the production of insect-resistant cultivars. For instance, as per the Statista Reports, In 2019, the United States had some of the most genetically modified seeds (71.5 million hectares), followed by Germany (a little more than 52.8 acres).

Also, international standards are there for the safety assessment of transgenic plants. For instance, the Organization for Economic Co-operation and Development (OECD) general agreement documents the safety evaluation of transgenic plants, including proximate, anti-nutritional molecules, natural toxins and food allergies, and other metabolic products characteristic of the species.

Further, cell culture methods are the most commonly used biopharmaceutical tools for fundamental and applied purposes ranging from germination and seedling process investigation, commercial micropropagation, creation of transgenic floras with particular industrial and crop yield traits, and genetic improvement, virus removal from infected components to render high-quality, and biotechnology and crop improvement.

Plant Tissue Culture Market
Know more about this reportrequest for sample pages

Report Segmentation

The market is primarily segmented based on stage, plant, crop type, end-use, and region.

By Stage

By Plant

By Crop Type

By End-Use

By Region

  • Explant preparation & Inoculation
  • Multiplication
  • Hardening
  • Annual
  • Biennial
  • Perennial
  • Banana
  • Floriculture
    • Gerbera
    • Carnation
    • Others
  • Wood Producing
  • Fruit
  • Vegetable
  • Ornamental
  • Aquatic
  • Others
  • Agriculture
  • Research
  • Gardening & Decoration
  • Forestry & Botanical Garden
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Spain, Netherlands, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this reportrequest for sample pages

Insight by End-Use

The agriculture segment is expected to be the most significant revenue contributor in the global market. This cell culture has become more and more prominent in agriculture. It is one method to commercialize a solution to the food shortage problem in developing countries, allowing them to manage their fast-increasing population in a limited amount of land, driving the plant tissue culture market growth.

Tissue culture enables propagators to conserve tissue DNA, create more vigorous crops, and ultimately save cost and enhance revenue. As a result, the cell culture is in high demand in the agricultural sector, driving plant tissue culture market expansion over the forecast period.

Geographic Overview

Asia Pacific had the largest revenue share in the global market. This dominance is attributable to the increasing incidences of cancers, growing government and nongovernment funding in tissue culture-based research, strong government backing, significant biopharmaceutical development expenditure, and greater advanced technologies in the Asia Pacific.

For instance, the Government of India's Department of Biotechnology (DBT) has independently allocated $640,000 to Hyderabad-based institutes Centre for Cellular and Molecular Biology (CCMB) and National Research Centre on Meat Science and Technology (NRCMST) in April 2021. The contribution is one of the greatest ever provided by a nation in cell-based meat research. It shows that India is prepared to make bold investments in the nutrition security of the world's rising population.

Also, the Department of Biotechnology (DBT), Govt. Of India has launched a Nationwide Certification System for Tissue Culture Raised Plants (NSC TCP) to produce and distribute high-quality culturing sowing materials. Thus, the government support for culture-based research and the various governmental organizations for assisting the tissue culture, among others, are boosting the regional growth. Moreover, North America is expected to witness a high CAGR in the global market in 2021. The region is expanding due to an increased understanding of tissue culture techniques usage.

Furthermore, the emphasis of major manufacturers on increasing their presence worldwide in rising North American countries to grab a large market share is likely to fuel the region's tissue culture market growth. For instance, in August 2021, Vita Farms and ForemostCo partnered to develop a new culturing lab, Vita Labs, in Guatemala to meet the demand for artificial tissue culture media. The new facility was established in response to a rise in global market demand for clean and healthy starting materials.

The epidemic has undoubtedly sparked a surge in market demand for attractive bonsai, resulting in well-documented demand and supply concerns. Vita Labs is a cutting-edge 8,000-square-foot facility that can generate 15 million plants per year when fully employed. Thus, the expansion of geographical presence and the establishment of new labs to generate clean and healthy plant materials are boosting regional growth.

Competitive Insight

Some of the major players operating in the global market include Alpha Laboratories, Agriforest Bio-Technologies, Booms Pharm, Caisson Laboratories, Inc., Australis Capital Inc., Labland Biotech Private Limited, Phytotech Laboratories, Inc., Phytoclone Inc., Rubi Bio LLC, Merck KGaA, Thomas Scientific (The Carlyle Group), and Tissue-Grown Corporation among others.

Plant Tissue Culture Market Report Scope

Report Attributes


Market size value in 2021

USD 390.0 Million

Revenue forecast in 2030

USD 791.3 Million


8.6% from 2022 - 2030

Base year


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD Million and CAGR from 2022 to 2030

Segments covered

By Stage, By Plant, By Crop Type, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Key companies

Alpha Laboratories, Agriforest Bio-Technologies, Booms Pharm, Caisson Laboratories, Inc., Australis Capital Inc., Labland Biotech Private Limited, Phytotech Laboratories, Inc., Phytoclone Inc., Rubi Bio LLC, Merck KGaA, Thomas Scientific (The Carlyle Group), and Tissue-Grown Corporation